This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Vertex Pharmaceuticals Inc (VRTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 1.39B 569.30M 489.41M 475.32M
Receivables 72.99M 85.52M 143.25M 183.14M
Inventories 30.85M 14.15M 30.46M 112.43M
Other Current Assets 57.19M 0.00 0.00 0.00
Total Current Assets 1.55B 1.59B 1.59B 1.33B
Property, Plant & Equipment, Gross 715.81M 1.01B 730.29M 404.24M
Accumulated Depreciation & Depletion n.a. 308.34M 296.68M 271.06M
Property, Plant & Equipment, Net 715.81M 696.91M 433.61M 133.18M
Intangibles 29.00M 0.00 663.50M 663.50M
Other Non-Current Assets 3.44M 2.56M 41.60M 45.36M
Total Non-Current Assets 788.17M 730.46M 1.17B 873.03M
Liabilities & Shareholder Equity
Total Assets 2.34B 2.32B 2.76B 2.20B
Accounts Payable 0.00 67.66M 130.30M 74.64M
Short Term Debt 0.00 16.89M 13.71M 0.00
Other Current Liabilities 323.70M 33.10M 41.53M 12.08M
Total Current Liabilities 414.83M 397.83M 432.62M 392.35M
Long Term Debt 294.78M 0.00 400.00M 400.00M
Deferred Income Taxes n.a. 0.00 280.37M 243.71M
Other Non-Current Liabilities 0.00 75.12M 167.24M 239.75M
Minority Interest -4.19M -242.52M 55.90M 11.60M
Total Non-Current Liabilities 825.30M 564.81M 1.33B 1.03B
Total Liabilities 1.24B 962.64M 1.76B 1.42B
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 1.10B 1.36B 999.18M 786.84M
Common Par n.a. 2.32M 2.15M 2.07M
Additional Paid In Capital 0.00 5.32B 4.52B 4.20B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -3.97B -3.52B -3.41B
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 1.10B -306.00K -550.00K -1.05M
Total Capitalization 1.39B 1.36B 1.40B 1.19B
Total Equity 1.10B 1.36B 999.18M 786.84M
Total Liabilities & Stock Equity 2.34B 2.32B 2.76B 2.20B
Total Common Shares Outstanding 240.52M 233.79M 217.29M 209.30M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 235.31M 224.91M 211.95M 204.89M
Diluted Weighted Shares Outstanding 235.31M 224.91M 211.95M 208.81M
Number of Employees NA 1800 2200 2000
Number of Part-Time Employees NA 0 0 0
VRTX News

VRTX Vertex Pharmaceuticals Inc

Analysts Ratings for VRTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 9 5 5 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VRTX ANALYST REPORT

Brokerage Partners

VRTX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs